Karpus Management, Inc.
Position in DMII — Drugs Made In America Acquisition II Corp.
CIK 1048703
Pittsford, NY
Position in DMII
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,047,259
+$2,145,967 QoQ
Shares Held
2,787,998
+7.3% QoQ
Ownership
4.38%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#1
of 74 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMII Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Jun 30, 2026Karpus Management, Inc. holds $739,032,997 across 108 Shell Companies names. DMII ranks #2 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SCII |
SC II Acquisition Corp.
|
2,942,837 | $29,516,655 | |
| 2 | DMII |
Drugs Made In America Acquisition II Corp.
This page
|
2,787,998 | $28,047,259 | |
| 3 | DMAA |
Drugs Made In America Acquisition Corp.
|
2,507,817 | $26,708,251 | |
| 4 | AACP |
Apogee Acquisition Corp
|
2,648,075 | $26,348,346 | |
| 5 | AIIA |
AI Infrastructure Acquisition Corp.
|
2,009,049 | $20,552,571 | |
| 6 | TAVI |
Tavia Acquisition Corp.
|
1,893,627 | $20,214,468 | |
| 7 | MKLY |
McKinley Acquisition Corp
|
1,825,871 | $18,532,590 | |
| 8 | 1,613,968 | $18,431,514 |
All Filings in DMII
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,047,259 | 2,787,998 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,901,292 | 2,597,923 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,321,887 | 1,143,625 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||